LPL Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53M | Buy |
16,240
+946
| +6% | +$272K | ﹤0.01% | 2711 |
|
|
2025
Q4 | $4.63M | Buy |
15,294
+1,314
| +9% | +$410K | ﹤0.01% | 2599 |
|
|
2025
Q3 | $3.92M | Buy |
13,980
+889
| +7% | +$242K | ﹤0.01% | 2695 |
|
|
2025
Q2 | $3.16M | Buy |
13,091
+7,717
| +144% | +$1.82M | ﹤0.01% | 2696 |
|
|
2025
Q1 | $1.31M | Buy |
5,374
+179
| +3% | +$53.8K | ﹤0.01% | 3318 |
|
|
2024
Q4 | $1.71M | Buy |
5,195
+1,326
| +34% | +$450K | ﹤0.01% | 3006 |
|
|
2024
Q3 | $1.29M | Buy |
3,869
+527
| +16% | +$167K | ﹤0.01% | 3147 |
|
|
2024
Q2 | $913K | Sell |
3,342
-711
| -18% | -$207K | ﹤0.01% | 3344 |
|
|
2024
Q1 | $1.4M | Sell |
4,053
-20,864
| -84% | -$6.86M | ﹤0.01% | 2880 |
|
|
2023
Q4 | $8.05M | Sell |
24,917
-7,420
| -23% | -$2.33M | ﹤0.01% | 1378 |
|
|
2023
Q3 | $11.6M | Buy |
32,337
+1,486
| +5% | +$573K | 0.01% | 1079 |
|
|
2023
Q2 | $11.7M | Buy |
30,851
+1,600
| +5% | +$651K | 0.01% | 1056 |
|
|
2023
Q1 | $14M | Buy |
29,251
+1,328
| +5% | +$622K | 0.01% | 915 |
|
|
2022
Q4 | $11.7M | Sell |
27,923
-61
| -0.2% | -$24.6K | 0.01% | 944 |
|
|
2022
Q3 | $11.7M | Buy |
27,984
+1,604
| +6% | +$800K | 0.01% | 881 |
|
|
2022
Q2 | $13.1M | Buy |
26,380
+1,607
| +6% | +$837K | 0.01% | 832 |
|
|
2022
Q1 | $14M | Buy |
24,773
+799
| +3% | +$482K | 0.01% | 818 |
|
|
2021
Q4 | $18.1M | Buy |
23,974
+2,986
| +14% | +$2.23M | 0.02% | 721 |
|
|
2021
Q3 | $15.7M | Sell |
20,988
-936
| -4% | -$701K | 0.01% | 731 |
|
|
2021
Q2 | $14.1M | Buy |
21,924
+1,762
| +9% | +$1.07M | 0.01% | 737 |
|
|
2021
Q1 | $11.5M | Buy |
20,162
+2,915
| +17% | +$1.73M | 0.01% | 760 |
|
|
2020
Q4 | $10.1M | Buy |
17,247
+2,637
| +18% | +$1.5M | 0.01% | 742 |
|
|
2020
Q3 | $7.53M | Buy |
14,610
+1,940
| +15% | +$983K | 0.01% | 753 |
|
|
2020
Q2 | $5.72M | Buy |
12,670
+2,472
| +24% | +$1.09M | 0.01% | 808 |
|
|
2020
Q1 | $3.58M | Buy |
10,198
+820
| +9% | +$301K | 0.01% | 889 |
|
|
2019
Q4 | $3.47M | Buy |
9,378
+973
| +12% | +$343K | 0.01% | 1017 |
|
|
2019
Q3 | $2.8M | Buy |
8,405
+691
| +9% | +$225K | 0.01% | 1062 |
|
|
2019
Q2 | $2.41M | Buy |
7,714
+1,763
| +30% | +$528K | 0.01% | 1147 |
|
|
2019
Q1 | $1.82M | Buy |
5,951
+966
| +19% | +$261K | ﹤0.01% | 1243 |
|
|
2018
Q4 | $1.16M | Buy |
4,985
+591
| +13% | +$159K | ﹤0.01% | 1423 |
|
|
2018
Q3 | $1.38M | Buy |
4,394
+519
| +13% | +$161K | ﹤0.01% | 1436 |
|
|
2018
Q2 | $1.12M | Sell |
3,875
-568
| -13% | -$157K | ﹤0.01% | 1550 |
|
|
2018
Q1 | $1.11M | Buy |
4,443
+1,074
| +32% | +$273K | ﹤0.01% | 1524 |
|
|
2017
Q4 | $804K | Buy |
3,369
+68
| +2% | +$16.5K | ﹤0.01% | 1695 |
|
|
2017
Q3 | $734K | Buy |
+3,301
| New | +$743K | ﹤0.01% | 1655 |
|
Other funds holding BIO
VCM
VPM
AI
